دورية أكاديمية

Development of KT-253, a Highly Potent and Selective Heterobifunctional MDM2 Degrader for the Treatment of Acute Myeloid Leukemia

التفاصيل البيبلوغرافية
العنوان: Development of KT-253, a Highly Potent and Selective Heterobifunctional MDM2 Degrader for the Treatment of Acute Myeloid Leukemia
المؤلفون: Mayo, Michele *, Chutake, Yogesh *, Karnik, Rahul *, McDonald, Alice *, Cho, Patricia S. *, Filiatrault, Jessica *, Chen, Dapeng *, Dixit, Vaishali *, Proctor, William *, Breitkopf, Susanne *, Qi, Frank *, Hu, Kan-Nian *, Sharma, Kirti *, Ewesuedo, Reggie *, Weiss, Matt *, Growney, Joseph D. *, Williams, Juliet *, Schalm, Stefanie S *
المصدر: In Blood 15 November 2022 140 Supplement 1:6239-6240
قاعدة البيانات: ScienceDirect
الوصف
تدمد:00064971
DOI:10.1182/blood-2022-169021